Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP)

  1. Sebastian Rehberg
  2. Sandra Frank
  3. Vladimír Černý
  4. Radek Cihlář
  5. Rainer Borgstedt
  6. Gianni Biancofiore
  7. Fabio Guarracino
  8. Andreas Schober
  9. Helmut Trimmel
  10. Thomas Pernerstorfer
  11. Christian Siebers
  12. Pavel Dostál
  13. Andrea Morelli
  14. Michael Joannidis
  15. Ingrid Pretsch
  16. Christian Fuchs
  17. Tim Rahmel
  18. Matej Podbregar
  19. Éva Duliczki
  20. Kadri Tamme
  21. Martin Unger
  22. Jan Sus
  23. Christoph Klade
  24. Kurt Krejcy
  25. Nairi Kirchbaumer-Baroian
  26. Günther Krumpl
  27. František Duška
  28. the LANDI-SEP Study Group
  29. Jan Brujevic
  30. Gottfried Heinz
  31. Claudia Spies
  32. Francesca Pratesi
  33. Andrej Markota
  34. Gintautas Kekstas
  35. Ákos Csomós
  36. Gabriella Kecskés
  37. Peter Sarkany
  38. Bela Fülesdi
  39. Rafal Wojtowicz
Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1007/s00134-024-07587-1
  2. Version published to 10.21203/rs.3.rs-4080750/v1 on Research Square